Linking Epithelial-Mesenchymal Transition to the Well-Known Polarity Protein Par6  by Thiery, Jean Paul & Huang, Ruby
Developmental Cell
456
first case (Figure 1A), one would predict that the acety- Patrick Brennwald
Department of Cell & Developmental Biologylation of a Sec4 GAP would act in a stimulatory fashion,
such that loss of Elongator would result in inhibition of University of North Carolina at Chapel Hill
Chapel Hill, North Carolina 27516the GAP and thus stabilization of Sec4-GTP. Alterna-
tively, the Sec4 exchange factor itself, Sec2p, could be
the target of Elongator regulation. In this model (Figure
1B), modification of Sec2p by Elongator would have an Selected Reading
inhibitory effect on Sec2 exchange activity. In this man-
Elkind, N.B., Walch-Solimena, C., and Novick, P.J. (2000). J. Cellner, Elongator deletion would result in increased Sec4
Biol. 149, 95–110.exchange activity. Conceivably, the acetyltransferase
Hawkes, N.A., Otero, G., Winkler, G.S., Marshall, N., Dahmus, M.E.,may act on other components involved in polarity es-
Krappmann, D., Scheidereit, C., Thomas, C.L., Schiavo, G., Erdju-tablishment and maintenance in addition to the exo-
ment-Bromage, H., et al. (2002). Mol. Cell 3, 109–188.
cytic apparatus.
Kozminski, K.G., Beven, L., Angerman, E., Tong, A.H., Boone, C.,Deficiencies in the human homolog of Elp1p, also
and Park, H.O. (2003). Mol. Biol. Cell 14, 4958–4970.
known as IKAP, are responsible for a neurodegenera-
Krogan, N.J., Kim, M., Ahn, S., Zohng, G., Kobor, M., Cagney, G.,tive disease called familial dysautonomia (FD). The neu-
Emili, A., Shilatifard, A., Buratowski, S., and Greenblatt, J.F. (2002).
ronal specificity of this defect is thought to be due to Mol. Cell. Biol. 22, 6979–6992.
a tissue-specific splicing defect manifested in neurons
Pokholok, D.K., Hannett, N.M., and Young, R.A. (2002). Mol. Cell 9,
(Slaugenhaupt and Gusella, 2002). IKAP is primarily 799–809.
found in a human-cell complex that is strikingly similar Rahl, P.B., Chen, C.Z., and Collins, R.N. (2005). Mol. Cell 17, 841–
to the yeast Elongator complex (Hawkes et al., 2002). 853.
This new work by Rahl et al. suggests a radically dif- Slaugenhaupt, S.A., and Gusella, J.F. (2002). Curr. Opin. Genet. Dev.
ferent model for the function of Elongator in yeast, 12, 307–311.
which if conserved in mammalian cells, would be of Walch-Solimena, C., Collins, R.N., and Novick, P.J. (1997). J. Cell
great importance in terms of understanding the normal Biol. 37, 1495–1509.
role that these proteins play in polarized trafficking, but Wittschieben, B.O., Otero, G., de Bizemont, T., Fellows, J., Erdju-
also in terms of understanding the underlying defect ment-Bromage, H., Ohba, R., Li, Y., Allis, C.D., Tempst, P., and
Svejstrup, J.Q. (1999). Mol. Cell 4, 123–128.contributing to familial dysautonomia.Developmental Cell, Vol. 8, April, 2005, Copyright ©2005 by Elsevier Inc. DOI 10.1016/j.devcel.2005.03.002k
F
l
c
e
Linking Epithelial-Mesenchymal
Transition to the Well-Known
Polarity Protein Par6
t
gEpithelial-mesenchymal transition (EMT) is involved
bin the formation of the body plan, tissue remodeling,
hand cancer progression. Two recent reports in Sci-
Eence (Barrios-Rodiles et al., 2005; Ozdamar et al.,
S2005) have decisively advanced our understanding of
tEMT. Par6 was identified as a key player in the control
tof tight junction (TJ) stability. This new study pro-
tvides further insight into the protein networks in-
volved in topologically regulated control of epithelial h
tcell polarity and plasticity.
dEMT converts epithelia into migratory mesenchymal
cells. EMT is a critical mechanism governing the forma- A
ftion of the body plan in most metazoans, and it also
plays a key role in diseases. Numerous studies using s
pepithelial cell lines have addressed the molecular
mechanisms controlling EMT, especially with respect to n
tunraveling tumor progression (Thiery, 2002). In most
model systems, EMT is induced by ligands of tyrosine hinase receptors such as c-Met, EGFR, IGF1R, and
GFR. A few studies have shown that some epithelial
ines can undergo EMT after activation of the TGFβ re-
eptor kinase (Grunert et al., 2003). Many studies have
mphasized a major role for signaling pathways leading
o the transcriptional repression of the E-cadherin
ene. Snail, a zinc finger transcriptional repressor, has
een extensively characterized, and its function in EMT
as been validated in vivo. Other repressors of the
-cadherin gene, including Slug, a close relative of
nail, SIP1, Twist, LIV1, and MTA3, have all been shown
o induce EMT (Kang and Massagué, 2004). In general,
he signaling pathways controlling EMT converge on
he control of E-cadherin, the prototypic epithelial ad-
esion molecule in adherens junctions (AJs). In con-
rast, the role of TJs has been neglected.
A better understanding of the control mechanism
riving EMT relies on better knowledge of how TJs,
Js, and desmosomes are assembled to produce the
ully polarized epithelial phenotype. During initial
tages of epithelial cell contact, spot-like AJs first ap-
ear at the tips of protrusions containing E-cadherin,
ectins, junctional adhesion molecule (JAM), and pro-
ein zonula occludens (ZO)-1 (Ebnet et al., 2004). E-cad-
erin mediates initial intercellular adhesion, which is
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457considerably strengthened after its connection to the
actin cytoskeleton via α- and β-catenin (Chu et al.,
2004). These initial contacts mature into AJs in cooper-
ation with nectins (Takai and Nakanishi, 2003), and they
promote the formation of TJs. In particular, JAM nu-
cleates clusters of two partitioning-defective proteins
(PAR3 and PAR6) and atypical PKC (aPKC) together
with claudin and occludin, which anchor the actin cy-
toskeleton through ZO-1, -2, and-3. Initiation of desmo-
somes is less understood.
The very recent work of Jeffrey Wrana and collabora-
tors (Barrios-Rodiles et al., 2005; Ozdamar et al., 2005)
provides crucial information about a control mecha-
nism regulating the stability of TJs as central regulators
of EMT. In their first paper, the development of high-
throughput luminescence-based mammalian interac-
tome mapping (LUMIER) permitted identification of a
TGFβ protein-protein interaction (PPI) network by using
a FLAG-tagged cDNA library representing sequences
containing a large variety of protein-interaction mod-
ules. A dynamic interaction network graph between
bait and prey molecules in the absence or presence of
TGFβ signaling was established by using semiquantita-
tive parameters for each interaction. One of the clusters
contains p21-activated kinase binding proteins and, by
serendipity, the TJ protein occludin. Subsequent analy-
sis revealed that occludin binds directly to the TGFβ
type I receptor (TGFβRI) and promotes its recruitment
to TJs. TGFβ induces the well-polarized NmuMG line
to undergo EMT by initially recruiting TGFβRII to TJs,
followed by TJ dissolution. These findings prompted
the authors to determine which proximal targets in the
TJ domain are affected by the activation of TGFβR.
In an accompanying paper, the authors report that
TGFβRI interacts directly with Par6. Upon exposure to
TGFβ, Par6 located in the occludin-TGFβRI complex is
phosphorylated on Ser345 by TGFβRII. Very interest-
ingly, mutating Par6 to eliminate this phosphorylationFigure 1. TGFβ Induces the Recruitment of
TGFβRII to the Preexisting TGFβRI-
Occludin-Par6 Complex
TGFβRII phosphorylates Par6, which then
binds to Smurf1. Smurf ubiquitinates RhoA,
which is degraded in the proteasome. Sub-
sequent loss of the actin network leads to
the disassembly of TJs, possibly followed by
AJ dissolution. However AJ disintegration
likely occurs through a Smad-dependent
pathway after transcriptional repression of
the E-cadherin gene. Colors are as follows:
blue, TJs; green, AJs; and purple, Desmo-
somes.site abrogates dissolution of TJs without affecting Smad
activation. As a consequence, part of the program for
EMT is still executed. The authors then showed that
phosphorylated Par6 binds to Smurf1, an E3 ubiquitin
ligase, which in turn mediates ubiquitination of RhoA.
Interfering RNA for Smurf1 and RhoA mutants lacking
ubiquitination sites inhibited TJ dissolution. These
studies have pioneered further research in the molecu-
lar dissection of EMT, because most previous studies
have not considered TJs to be a primary target in EMT.
Previous lack of emphasis on this issue may be attribut-
able to difficulties analyzing TJs during initial EMT
events in embryos and to the fact that most cell lines
used in in vitro studies lack TJs.
Par6 may have several distinct functions other than
being just a central effector of EMT. Par6 binds to many
regulatory proteins, including PALS1 (a Stardust or-
tholog in the Crumbs complex), Lethal giant larvae (Lgl,
which together with Scribble and Disc Large partici-
pates in the establishment of cell polarity), and the
Fragile X-Lgl complex involved in cytoplasmic trans-
port of ribonucleoproteins and anchoring to specific
plasma membrane domains (Zarnescu et al., 2005).
These findings will prompt further investigations to un-
ravel the role of other TJ-associated scaffold proteins,
because inhibition of Par6 phosphorylation and RhoA
ubiquitination only partially prevent TJ dissolution. Par3
is also a key player in the control of TJ formation
through the localized regulation of Rac activity (Chen
and Macara, 2005). It will also be important to deter-
mine how Smad-dependent and Smad-independent
pathways cooperate to accomplish the full program of
EMT (Figure 1).
It is intriguing to see that surface receptors, such as
TGFβR, controlling EMT are targeted to TJs. In con-
trast, other EMT-inducing receptors, including EGFR,
c-Met, and IGF1-R, colocalize in AJs, physically in-
teracting with E-cadherin. Bidirectional regulation be-
tween these two classes of receptors is now known to
affect EMT (Qian et al., 2004). It raises, however, the
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458Squestion of how EMT-inducing receptors can be ac-
cessed by their cognate ligands in fully polarized epi-
Bthelial cells with sealed cell junctions. The role of the
Dsmall GTPase CDC42, which can be activated during
(its interaction with Par 6, also needs to be clarified in
Cthe formation and breakdown of TJs. Finally, the func-
Ction of RhoA—another important effector of TJ assem-
ably—needs to be investigated further because of its op-
Eposite action on the actin cytoskeleton through either
S
mDia or ROCK.
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